Novartis Company IP News and Updates

As the relentless march of time continues, pharmaceutical executives find themselves facing the inevitability of patent expirations and the subsequent...

BeiGene, a biotechnology company, has taken legal action by filing patent infringement lawsuits against pharmaceutical companies Sandoz and MSN Pharmaceuticals,...

ARGENTUM PHARM. LLC v. NOVARTIS PHARM. CORP. Before Lourie, Moore, and Reyna.  Appeal from the U.S. Patent and Trademark Office,...

In Novartis Pharm. v. West-Ward Pharm., Appeal no. 2018-1434 (Fed. Cir., May 12, 2019), a three judge panel of Stoll,...

CASE OF THE WEEK AVX Corporation v. Presidio Components, Inc., Appeal No. 2018-1106 (Fed. Cir. May 13, 2019) Following an...

NOVARTIS PHAMACEUTICALS CORP V. WEST-WARD PHARMACEUTICALS Before Stoll, Plager, and Clevenger.  Appeal from the United States District Court for the...

    Federal Circuit Summary   Before Prost, Wallach, and Chen.  Appeal from the United States District Court for the...

CASE OF THE WEEK Jack Henry & Associates, Inc. v. Plano Encryption Technologies LLC, Appeal No. 2016-2700 (Fed. Cir. Dec....

2017: A Year of CAFC Feedback & Agency Refocus With so much attention being paid to Oil States, it was...

After Novartis’ patents were found nonobvious by the Fed. Cir., affirming the Delaware District Court, defendant Noven filed for inter...